Name
AstraPharm OÜ
Registry code
14906879
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
07.02.2020 (4)
Financial year
01.01-31.12
Capital
10 000.00 €
Activity
47731 - Dispensing chemist in specialised stores
583 511 €
195 085 €
33%
1 514 €
(estimate is approximate)
377 681 €
2
Submitted
No tax arrears
52%
52%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Irina Merkur 06.04.1981 (43) | 90% - 9 000.00 EUR | Board member | Direct ownership | Founder |
| Silkest OÜ 14721795 | 10% - 1 000.00 EUR | - | - | Founder |
| Ivan Kuznetsov 26.03.1984 (40) | - | Board member | Indirect ownership | |
| Selma Patrícia Pereira Lopes Kuznetsova 07.06.1983 (41) | - | - | Indirect ownership |
| 2020 05.07.2021 | 2021 22.06.2022 | 2022 26.06.2023 | 2023 11.05.2024 | |
|---|---|---|---|---|
| Total Revenue | 444 175 € | 814 175 € | 613 593 € | 583 511 € |
| Net profit (loss) for the period | 21 682 € | 118 287 € | 40 126 € | 195 085 € |
| Profit Margin | 5% | 15% | 7% | 33% |
| Current Assets | 247 980 € | 258 002 € | 338 522 € | 377 758 € |
| Fixed Assets | 2 083 € | 1 083 € | 83 € | 0 € |
| Total Assets | 250 063 € | 259 085 € | 338 605 € | 377 758 € |
| Current Liabilities | 189 131 € | 116 616 € | 156 009 € | 77 € |
| Non Current Liabilities | 36 750 € | 0 € | - | - |
| Total Liabilities | 225 881 € | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 24 182 € | 142 469 € | 182 596 € | 377 681 € |
| Employees | 4 | 4 | 4 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | - | - | - |
| 2023 Q4 | 163 268.79 € | 16 593.77 € | 4 016.08 € | - |
| 2023 Q3 | 148 217.78 € | 10 052.37 € | 5 484.62 € | 6 |
| 2023 Q2 | 168 052.48 € | 10 921.55 € | 4 965.64 € | 6 |
| 2023 Q1 | 174 140.73 € | 7 333.65 € | 4 383.38 € | 6 |
| 2022 Q4 | 158 254.29 € | 8 601 € | 5 856.7 € | 7 |
| 2022 Q3 | 133 496.74 € | 9 125.84 € | 6 310.2 € | 7 |
| 2022 Q2 | 145 040.17 € | 8 312.34 € | 4 744.16 € | 7 |
| 2022 Q1 | 177 985.16 € | 5 867.61 € | 2 376.61 € | 7 |
| 2021 Q4 | 179 018.02 € | 10 755.9 € | 4 973.49 € | 4 |
| 2021 Q3 | 194 392.92 € | 13 806.29 € | 6 664.47 € | 6 |
| 2021 Q2 | 263 170.07 € | 14 143.42 € | 6 732.74 € | 9 |
| 2021 Q1 | 193 545.56 € | 7 707.1 € | 5 228.6 € | 7 |
| 2020 Q4 | 204 725.18 € | 8 463.26 € | 7 703.79 € | 8 |
| 2020 Q3 | 72 853.09 € | 4 605.53 € | 4 539.72 € | 8 |
| 2020 Q2 | 76 037.66 € | 2 288.94 € | 1 473.22 € | 6 |
| 2020 Q1 | - | - | - | 3 |
